Search research articles
Contact Us
Filters
Showing results (301-310 of 345) with videos related to
Page
of 35
Sort By:
Cancer Nursing
|
October 5, 2021
The Added Value of Family Caregivers' Level of Mastery in Predicting Survival of Glioblastoma Patients: A Validation Study
Florien W Boele, Jason Weimer, Amir H Zamanipoor Najafabadi, et al.
Journal of Neuro-Oncology
|
September 4, 2003
Autologous glioma cell vaccine admixed with interleukin-4 gene transfected fibroblasts in the treatment of recurrent glioblastoma: preliminary observations in a patient with a favorable response to therapy
Hideho Okada, Frank S Lieberman, Howard D Edington, et al.
Annals of Epidemiology
|
September 7, 2010
Long-term health experience of jet engine manufacturing workers: IV. A comparison of central nervous system cancer ascertainment using mortality and incidence data
Jeanine M Buchanich, Ada O Youk, Gary M Marsh, et al.
Journal of Occupational and Environmental Medicine
|
May 30, 2013
Long-term health experience of jet engine manufacturing workers: results from a 12-year exploratory investigation
Gary M Marsh, Jeanine M Buchanich, Ada O Youk, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 30, 2018
Phase 2 Study of Radiation Therapy Plus Low-Dose Temozolomide Followed by Temozolomide and Irinotecan for Glioblastoma: NRG Oncology RTOG Trial 0420
Frank S Lieberman, Meihua Wang, H Ian Robins, et al.
Neuroepidemiology
|
June 5, 2010
Long-term health experience of jet engine manufacturing workers: III. Incidence of malignant central nervous system neoplasms
Gary M Marsh, Jeanine M Buchanich, Ada O Youk, et al.
Neuro-Oncology
|
March 8, 2011
A phase I/II trial of the histone deacetylase inhibitor romidepsin for adults with recurrent malignant glioma: North American Brain Tumor Consortium Study 03-03
Fabio M Iwamoto, Kathleen R Lamborn, John G Kuhn, et al.
Cancer Chemotherapy and Pharmacology
|
October 3, 2007
Phase I clinical trial of intrathecal gemcitabine in patients with neoplastic meningitis
Ronald J Bernardi, Lisa Bomgaars, Elizabeth Fox, et al.
Neuro-Oncology
|
December 19, 2015
Targeted next-generation sequencing panel (GlioSeq) provides comprehensive genetic profiling of central nervous system tumors
Marina N Nikiforova, Abigail I Wald, Melissa A Melan, et al.
Journal of Neuro-Oncology
|
October 21, 2023
Activity of a first-in-class oral HIF2-alpha inhibitor, PT2385, in patients with first recurrence of glioblastoma
Roy Strowd, Benjamin Ellingson, Catalina Raymond, et al.
Page
of 35
Search research articles
Search
Showing results (301-310 of 345) with videos related to
Sort By:
Page
of 35
Cancer Nursing
|
October 5, 2021
The Added Value of Family Caregivers' Level of Mastery in Predicting Survival of Glioblastoma Patients: A Validation Study
Florien W Boele, Jason Weimer, Amir H Zamanipoor Najafabadi, et al.
Journal of Neuro-Oncology
|
September 4, 2003
Autologous glioma cell vaccine admixed with interleukin-4 gene transfected fibroblasts in the treatment of recurrent glioblastoma: preliminary observations in a patient with a favorable response to therapy
Hideho Okada, Frank S Lieberman, Howard D Edington, et al.
Annals of Epidemiology
|
September 7, 2010
Long-term health experience of jet engine manufacturing workers: IV. A comparison of central nervous system cancer ascertainment using mortality and incidence data
Jeanine M Buchanich, Ada O Youk, Gary M Marsh, et al.
Journal of Occupational and Environmental Medicine
|
May 30, 2013
Long-term health experience of jet engine manufacturing workers: results from a 12-year exploratory investigation
Gary M Marsh, Jeanine M Buchanich, Ada O Youk, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 30, 2018
Phase 2 Study of Radiation Therapy Plus Low-Dose Temozolomide Followed by Temozolomide and Irinotecan for Glioblastoma: NRG Oncology RTOG Trial 0420
Frank S Lieberman, Meihua Wang, H Ian Robins, et al.
Neuroepidemiology
|
June 5, 2010
Long-term health experience of jet engine manufacturing workers: III. Incidence of malignant central nervous system neoplasms
Gary M Marsh, Jeanine M Buchanich, Ada O Youk, et al.
Neuro-Oncology
|
March 8, 2011
A phase I/II trial of the histone deacetylase inhibitor romidepsin for adults with recurrent malignant glioma: North American Brain Tumor Consortium Study 03-03
Fabio M Iwamoto, Kathleen R Lamborn, John G Kuhn, et al.
Cancer Chemotherapy and Pharmacology
|
October 3, 2007
Phase I clinical trial of intrathecal gemcitabine in patients with neoplastic meningitis
Ronald J Bernardi, Lisa Bomgaars, Elizabeth Fox, et al.
Neuro-Oncology
|
December 19, 2015
Targeted next-generation sequencing panel (GlioSeq) provides comprehensive genetic profiling of central nervous system tumors
Marina N Nikiforova, Abigail I Wald, Melissa A Melan, et al.
Journal of Neuro-Oncology
|
October 21, 2023
Activity of a first-in-class oral HIF2-alpha inhibitor, PT2385, in patients with first recurrence of glioblastoma
Roy Strowd, Benjamin Ellingson, Catalina Raymond, et al.
Page
of 35